Adage Capital Partners’s iRadimed IRMD Stock Holding History

Adage Capital Partners’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-55,900	Closed	-$805K	–	763
2018 Q1	$805K	Buy	+55,900	New	+$796K	﹤0.01%	693

Other funds holding IRMD

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

CCM

Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Adage Capital Partners's IRMD Position: Q2 2018 in Review

Adage Capital Partners sold out of iRadimed (IRMD) in Q2 2018, closing a stake of 55,900 shares — an estimated $805K sold.

Adage Capital Partners first reported a position in IRMD in Q1 2018 and held it in 1 quarter. The position peaked at $805K in Q1 2018. 51 funds tracked by Wall St. Rank hold IRMD as of Q2 2018.

Adage Capital Partners reported no remaining iRadimed position as of Q2 2018 after selling out during the quarter.
Adage Capital Partners sold 55,900 iRadimed shares in Q2 2018, an estimated $805K.
Adage Capital Partners first reported a position in iRadimed in Q1 2018 and held it in 1 quarter.
Adage Capital Partners's iRadimed position peaked at $805K in Q1 2018.
51 funds tracked by Wall St. Rank held iRadimed as of Q2 2018.

Based on Adage Capital Partners's 13F filing for Q2 2018, filed 14 Aug 2018.